Quality Policy

REVEAL GENOMICS, S.L. is a biotechnology start-up seeking to change the way biomarkers are used in oncology. It is focused on developing, manufacturing and delivering innovative in vitro diagnostic test to define the best therapeutic options for patients with cancer. The company uses pioneering techniques, sophisticated computer applications, and machine learning to reveal new cancer research data.

The Leadership of Reveal Genomics, SL expresses its commitment to the Quality Management System and actively encourages all staff members to integrate quality practices into their daily activities and to participate fully in the implementation and enhancement of our quality processes.

Reveal Genomics, SL ensures the quality of its products and services by implementing a Quality Management System in accordance with UNE-EN-ISO 13485, Regulation UE 2017/746 and other regulatory requirements.

The defined Quality Policy is focused on enhancing the following actions:

To provide innovative solutions.
To ensure the safety and efficacy of our products through rigorous testing and validation.
To know the needs and expectations of our customers to ensure the provision of adequate, safe, reliable, compliant products and services.
To seek excellence, continuous improvement and customer satisfaction.
To comply with applicable legal and regulatory requirements.
To establish and maintain process management, monitoring their conformity and measuring their effectiveness.
To maintain the right conditions in the different areas of work of the company to ensure the safety of our staff, as well as respect for the environment.

We are convinced that the establishment, achievement and review of the proposed objectives and indicators will benefit everyone and lead to better development of the company.

To successfully achieve these purposes, the Leadership will provide the necessary resources and support.

In Barcelona, June 19th, 2024

Patricia Villagrasa

CEO